Munyaradzi Musvosvi

Munya obtained his PhD at the University of Cape Town in 2015 and completed a postdoc at the South African Tuberculosis Vaccine Initiative in 2020. He is currently a research officer at the South African Tuberculosis Vaccine Initiative. Munya is interested in understanding the role of antigen-specific T cells in control of M.tb infection with the hope that these insights will be valuable to novel vaccine designs. He is also working on project that are assessing promising TB biomarkers with the aim of moving them closer to clinical translation.